Applied DNA Systems, Inc., of Warwick, Rhode Island, has elected J.Marvin Feigenbaum chairman of the board and CEO.Applied Immune Sciences Inc. of Santa Clara, Calif., has announcedthat Judith Weissinger, has joined AIS as vice president of regulatoryaffairs.Calgene Inc., of Davis, Calif., has promoted Don Emlay and BillHiggins to the position of vice president.Diagnon, Corporation, of Rockville, Md., appointed Michael PO'Flaherty to chief operating officer.Innovir Laboratories Inc., of New York, elected Allan Goldberg, thecompany's chairman and president, to the post of CEO.Ixsys Inc., of San Diego, appointed John A. Kenward president andCEO. Kenward was formerly executive vice president and chiefoperating officer of Repligen Corp.North American Vaccine, of Beltsville, Md., appointed Wayne Morgesto the position of vice president-manufacturing operations.Paradigm Biosciences Inc., of Salt Lake City, appointed Martin M.McGlynn as president and CEO.RIBI ImmunoChem, of Hamilton, Mont., appointed Lonnie L.Bookbinder as vice president, director of corporate development.Larry Couture, has joined Ribozyme Pharmaceuticals Inc., of Boulder,Colo, as a senior scientist.Hemasure Inc., of Marlborough, Mass., appointed James B. Murphy asvice prsident and controller.Harvey L. Kellman has been named president of Sheffield MedicalTechnologies Inc., of Houston.Synergen Inc., of Boulder, Colo., appointed Paul Koivuniemi vicepresident and general counsel, Scott C. Stromatt as vice president,clinical research, and Giles V. Campion, vice president, clinicalresearch.Systemix Inc., of Palo Alto, Calif., appointed Wendy R. Hitchcock, tothe position of chief financial officer.Paradigm Biosciences Inc., of Salt Lake City, has appointed MartinMcGlynn as president and CEO.Texas Biotechnology Corp., of Houston, elected James Thomson to theboard of directors.Emisphere Technologies Inc., of Hawthorne, N.Y., named Jeffery B.Press as vice president and director of research.Amylin Pharmaceuticals Inc., of San Diego, announced theappointments of Robert G. Thompson to vice president, James J.L'Italien to senior director of pharmaceutical chemistry and MartinBrown to Director of Information Technology.

(c) 1997 American Health Consultants. All rights reserved.